Multiple studies have demonstrated that EGCG could activate the PI3K/AKT signaling to improve learning and memory retention, inhibit sevoflurane-induced neurodegeneration [52], modulate neurogenesis and stroke recovery [53, 54], and promote cell growth and neuron differentiation [55]. This evidence concerns the gene AKT1 and stroke disorder.